• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION EXPRESS LD ILIAC / BILIARY; STENT, ILIAC

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION EXPRESS LD ILIAC / BILIARY; STENT, ILIAC Back to Search Results
Model Number 20226
Device Problems Device Damaged by Another Device (2915); Material Deformation (2976)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 12/15/2022
Event Type  malfunction  
Event Description
It was reported that stent damage occurred.The target lesion was located in the superficial femoral artery.A 7.0x30x135cm express ld stent was advanced for treatment.However, the device was caught on the sheath and the stent was defective.Subsequently, another 7.0x30x135cm express ld stent was advanced.The second device was also caught on the sheath and defective.Both devices were retrieved, and the procedure was completed with a different device.There were no patient complications reported and the patient status was stable.
 
Event Description
It was reported that stent damage occurred.The target lesion was located in the superficial femoral artery.A 7.0x30x135cm express ld stent was advanced for treatment.However, the device was caught on the sheath and the stent was defective.Subsequently, another 7.0x30x135cm express ld stent was advanced.The second device was also caught on the sheath and defective.Both devices were retrieved, and the procedure was completed with a different device.There were no patient complications reported and the patient status was stable.
 
Manufacturer Narrative
Device evaluated by mfr.: this express ld device was received for analysis.The balloon was received tightly folded which indicates it had not been subjected to positive pressure.The stent was pushed over the proximal markerband and proximal balloon bond and part of shaft.The stent was slightly expanded due to the breadth of the proximal balloon bond.No damage or issues were noted with balloon material that could potentially have contributed to the complaint incident.A visual and tactile examination identified no kinks or damage to the shaft of the device.A visual examination of the device identified no issues with the tip that could have contributed to the complaint incident.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
EXPRESS LD ILIAC / BILIARY
Type of Device
STENT, ILIAC
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
two scimed place
maple grove MN 55311
Manufacturer (Section G)
BOSTON SCIENTIFIC CORPORATION
ballybrit business park
galway
EI  
Manufacturer Contact
jay johnson
4100 hamline ave n
arden hills, MN 55112
6515810888
MDR Report Key16109468
MDR Text Key308361405
Report Number2124215-2022-54604
Device Sequence Number1
Product Code NIO
UDI-Device Identifier08714729579694
UDI-Public08714729579694
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K133110
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 02/03/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received01/05/2023
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model Number20226
Device Catalogue Number20226
Device Lot Number0030216595
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? Yes
Date Manufacturer Received01/12/2023
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured09/26/2022
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
-
-